Aurora Cannabis (ACB) Return on Sales (2017 - 2026)

Aurora Cannabis (ACB) has reported Return on Sales for 10 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• Quarterly Return on Sales fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 30.0% YoY) and the FY2026 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales declined to 0.01% in Q1 2026 per ACB's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for ACB reached as high as 0.02% in Q2 2024 and fell as low as 1.13% in Q3 2024.
• A 5-year average of 0.1% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2024 — Return on Sales slumped 107 bps — and 2025, when it soared 113 bps.
• Year by year, Return on Sales stood at 0.0% in 2022, then jumped by 86 bps to 0.0% in 2023, then surged by 108 bps to 0.0% in 2024, then slumped by 206 bps to 0.0% in 2025, then sank by 47615 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.